lab-on-a-chip

DNANudge is developing an at-home testing kit, based on DNAe's semiconductor technology, to screen around 50 SNPs associated with nutrition and metabolism.

Drop to Drop

Not every drop of blood is the same, according to researchers from Rice University.

The San Diego-based firm will use the Series C investment and convertible debt to land regulatory clearance for its cancer treatment response assay.

NEW YORK (GenomeWeb) – Contract research organization Nanosyn today announced a multiyear research service agreement to provide its microfluidics screening and profiling capabilities to Forma Therapeutics.

NEW YORK (GenomeWeb News) – A consortium of European research institutions and private partners will use €5.3 million ($7.4 million) in funding to develop a microfluidics-based lab-on-a-chip device to identify and measure the concentration of circulating tumor cells in blood, one of the partners,

NEW YORK (GenomeWeb News) – The Johns Hopkins University and Imec today announced a collaboration to "expand healthcare applications" for silicon nanotechnology.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Agilent Technologies today said that it will collaborate with the US Food and Drug Administration on food testing applications.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Siemens has put its lab-on-a-chip technology up for sale.

ADA will develop the technology to identify biological hazards in complex matrices.

Pages

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.